(Q38212715)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

title

Multiparametric MRI in prostate cancer management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

2

Baris Turkbey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

4

Peter L Choyke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

author name string

Linda M Johnson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

William D Figg

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

language of work or name

English

0 references

publication date

20 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840072%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Clinical Oncology

18 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

page(s)

346-353

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Incidence of impalpable carcinoma of the prostate and of non-malignant and precarcinomatous lesions in Greek male population: an autopsy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

21 January 2018

Overdiagnosis in cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

ESUR prostate MR guidelines 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Impact of delay after biopsy and post-biopsy haemorrhage on prostate cancer tumour detection using multi-parametric MRI: A multi-reader study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

The role of magnetic resonance imaging in the diagnosis and management of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Prostate MRI: who, when, and how? Report from a UK consensus meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Imaging in oncology from the University of Texas M. D. Anderson Cancer Center: diagnosis, staging, and surveillance of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

A clinically relevant approach to imaging prostate cancer: review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Staging of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Clinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Can we predict real T3 stage prostate cancer in patients with clinical T3 (cT3) disease before radical prostatectomy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Contribution of the MR spectroscopic imaging in the diagnosis of prostate cancer in the peripheral zone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Diagnosis of prostate cancer in patients with an elevated prostate-specific antigen level: role of endorectal MRI and MR spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Endorectal MR imaging before salvage prostatectomy: tumor localization and staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Spin Diffusion Measurements: Spin Echoes in the Presence of a Time-Dependent Field Gradient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Diffusion-weighted MRI of the abdomen: current value in clinical routine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Increased signal intensity of prostate lesions on high b-value diffusion-weighted images as a predictive sign of malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Usefulness of diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Correlation of magnetic resonance imaging tumor volume with histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Transition zone prostate cancer: incremental value of diffusion-weighted endorectal MR imaging in tumor detection and assessment of aggressiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Seminal vesicle invasion in prostate cancer: evaluation by using multiparametric endorectal MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Modern role of magnetic resonance and spectroscopy in the imaging of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Endorectal coil MRI and MR-spectroscopic imaging in patients with elevated serum prostate specific antigen with negative trus transrectal ultrasound guided biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Angiogenesis in prostate cancer: biology and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Functional and molecular imaging of localized and recurrent prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Prostate cancer imaging: what the urologist wants to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Detection of prostate cancer in peripheral zone: comparison of MR diffusion tensor imaging, quantitative dynamic contrast-enhanced MRI, and the two techniques combined at 3.0 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Detection and localization of prostate cancer with the targeted biopsy strategy based on ADC map: a prospective large-scale cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Computed diffusion-weighted imaging of the prostate at 3 T: impact on image quality and tumour detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Optimal Timing of Post-Biopsy Mr Imaging of the Prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Value of prostate multiparametric magnetic resonance imaging for predicting biopsy results in first or repeat biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

OPTIMAL TIMING OF POST-BIOPSY MR IMAGING OF THE PROSTATE

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Accuracy of preoperative endorectal MRI in predicting extracapsular extension and influence on neurovascular bundle sparing in radical prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Isolated seminal vesicle invasion imparts better outcomes after radical retropubic prostatectomy for clinically localized prostate cancer: prognostic stratification of pt3b disease by nodal and margin status

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Endorectal magnetic resonance imaging staging of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Combined T2-Weighted and Diffusion-Weighted MRI for Localization of Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

A comparison of transrectal ultrasonography and endorectal magnetic resonance imaging in the local staging of prostatic carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Local staging of prostate cancer with endorectal surface coil MR imaging in a mid-field magnetic system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Phased-array magnetic resonance imaging of the prostate with correlation to radical prostatectomy specimens: local experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Computed diffusion-weighted imaging using 3-T magnetic resonance imaging for prostate cancer diagnosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: correlation with stepwise histopathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Dynamic contrast-enhanced MRI for prostate cancer localization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Microvascularity in benign prostatic hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Combined Multiparametric MRI and Targeted Biopsies Improve Anterior Prostate Cancer Detection, Staging, and Grading

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Dynamic Contrast Enhanced, Pelvic Phased Array Magnetic Resonance Imaging of Localized Prostate Cancer for Predicting Tumor Volume: Correlation With Radical Prostatectomy Findings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Dynamic Contrast-enhanced–magnetic Resonance Imaging Evaluation of Intraprostatic Prostate Cancer: Correlation with Radical Prostatectomy Specimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Role of multiparametric magnetic resonance imaging (MRI) in focal therapy for prostate cancer: a Delphi consensus project

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.69

Prostate cancer screening: issues and controversies

31 March 2020

1 reference

12 December 2020

Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology

1 reference

12 December 2020

Utility of ADC measurement on diffusion-weighted MRI in differentiation of prostate cancer, normal prostate and prostatitis.

1 reference

12 December 2020

Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study

1 reference

12 December 2020

Active surveillance or active treatment in localized prostate cancer?

1 reference

12 December 2020

Local experience of endorectal magnetic resonance imaging of prostate with correlation to radical prostatectomy specimens

1 reference

12 December 2020

Prostatic MR imaging. Accuracy in differentiating cancer from other prostatic disorders.

1 reference

12 December 2020

10.1038/NRCLINONC.2014.69

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840072%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840072%20AND%20SRC:MED&resulttype=core&format=json